BRPI0506400A8 - Uso de um composto para a fabricação de um medicamento para o tratamento de tuberculose latente - Google Patents
Uso de um composto para a fabricação de um medicamento para o tratamento de tuberculose latenteInfo
- Publication number
- BRPI0506400A8 BRPI0506400A8 BRPI0506400A BRPI0506400A BRPI0506400A8 BR PI0506400 A8 BRPI0506400 A8 BR PI0506400A8 BR PI0506400 A BRPI0506400 A BR PI0506400A BR PI0506400 A BRPI0506400 A BR PI0506400A BR PI0506400 A8 BRPI0506400 A8 BR PI0506400A8
- Authority
- BR
- Brazil
- Prior art keywords
- alkyl
- hydrogen
- het
- compound
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04078529 | 2004-12-24 | ||
EP04078529.7 | 2004-12-24 | ||
EP05105008.6 | 2005-06-08 | ||
EP05105008 | 2005-06-08 |
Publications (4)
Publication Number | Publication Date |
---|---|
BRPI0506400A BRPI0506400A (pt) | 2006-08-29 |
BRPI0506400A8 true BRPI0506400A8 (pt) | 2017-09-12 |
BRPI0506400B1 BRPI0506400B1 (pt) | 2021-04-06 |
BRPI0506400B8 BRPI0506400B8 (pt) | 2021-05-25 |
Family
ID=35717702
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0506400A BRPI0506400B8 (pt) | 2004-12-24 | 2005-12-08 | uso de um composto para a fabricação de um medicamento para o tratamento de tuberculose latente |
Country Status (31)
Country | Link |
---|---|
US (1) | US20060142279A1 (pt) |
EP (1) | EP1830850B1 (pt) |
CN (1) | CN103142595B (pt) |
AP (1) | AP2327A (pt) |
AR (1) | AR051790A1 (pt) |
AT (1) | ATE501721T1 (pt) |
AU (1) | AU2005242138B2 (pt) |
BR (1) | BRPI0506400B8 (pt) |
CA (1) | CA2529265C (pt) |
CR (1) | CR9267A (pt) |
CY (1) | CY1112247T1 (pt) |
DE (1) | DE602005026984D1 (pt) |
DK (1) | DK1830850T3 (pt) |
EE (1) | EE05394B1 (pt) |
HK (1) | HK1186125A1 (pt) |
HR (1) | HRP20110392T1 (pt) |
IL (1) | IL184123A (pt) |
LV (1) | LV13469B (pt) |
ME (1) | ME01207B (pt) |
MY (1) | MY145845A (pt) |
NI (1) | NI200700146A (pt) |
NO (1) | NO340376B1 (pt) |
NZ (1) | NZ555460A (pt) |
PA (1) | PA8654801A1 (pt) |
PL (1) | PL1830850T3 (pt) |
PT (1) | PT1830850E (pt) |
RS (1) | RS51730B (pt) |
SI (1) | SI1830850T1 (pt) |
TR (1) | TR200504892A1 (pt) |
TW (1) | TWI404535B (pt) |
WO (1) | WO2006067048A1 (pt) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA05001052A (es) * | 2002-07-25 | 2005-04-08 | Janssen Pharmaceutica Nv | Derivados de quinolina y su uso como inhibidores micobacterianos. |
JO3270B1 (ar) * | 2005-06-28 | 2018-09-16 | Janssen Pharmaceutica Nv | مشتقات كوينولين بصفة عوامل مضادة للبكتيريا |
SG166798A1 (en) * | 2005-06-28 | 2010-12-29 | Janssen Pharmaceutica Nv | Quinolone derivatives as antibacterial agents |
JO2752B1 (en) * | 2005-06-28 | 2014-03-15 | شركة جانسين فارماسوتيكا ان. في | Quinoline derivatives acting as antibacterial agents |
JO2970B1 (en) * | 2006-12-06 | 2016-03-15 | جانسين فارماسوتيكا ان. في | Quinoline antibacterial derivatives |
JO2725B1 (en) * | 2006-12-06 | 2013-09-15 | جانسين فارماسوتيكا ان. في | Quinoline antibacterial derivatives |
JO3271B1 (ar) | 2006-12-06 | 2018-09-16 | Janssen Pharmaceutica Nv | مشتقات الكوينولين المضادة للجراثيم |
JO2683B1 (en) * | 2006-12-06 | 2013-03-03 | جانسين فارماسوتيكا ان. في | Quinoline antibacterial derivatives |
WO2009091324A1 (en) * | 2008-01-14 | 2009-07-23 | Jyoti Chattopadhyaya | Quinoline, naphthalene and conformationally constrained quinoline or naphthalene derivates as anti-mycobacterial agents |
RU2404971C2 (ru) * | 2008-12-02 | 2010-11-27 | ЗАО "Фарм-Синтез" | Новые производные хинолина, способ их получения, их применение для лечения микобактериальных инфекций, фармацевтическая композиция на их основе |
US8741917B2 (en) | 2009-01-15 | 2014-06-03 | Rutgers, The State University Of New Jersey | Benzo [C] phenanthridines as antimicrobial agents |
US20120059026A1 (en) | 2009-04-30 | 2012-03-08 | University Of Medicine And Dentistry Of New Jersey | Antimicrobial agents |
WO2011156626A1 (en) | 2010-06-09 | 2011-12-15 | Rutgers, The State University Of New Jersey | Antimicrobial agents |
US9102617B2 (en) | 2010-06-25 | 2015-08-11 | Rutgers, The State University Of New Jersey | Antimicrobial agents |
US9822108B2 (en) | 2012-01-13 | 2017-11-21 | Rutgers, The State University Of New Jersey | Antimicrobial agents |
US9475783B2 (en) | 2012-03-21 | 2016-10-25 | Rutgers, The State University Of New Jersey | Antimicrobial agents |
WO2013160431A1 (en) | 2012-04-27 | 2013-10-31 | Janssen Pharmaceutica Nv | Antibacterial quinoline derivatives |
CA2869718C (en) | 2012-04-27 | 2021-05-11 | Janssen Pharmaceutica Nv | Antibacterial quinoline derivatives |
US9458150B2 (en) | 2013-11-08 | 2016-10-04 | Rutgers, The State University Of New Jersey | Antimicrobial agents |
EP3250182B1 (en) | 2015-01-27 | 2023-04-26 | Janssen Pharmaceutica NV | Dispersible compositions |
JP2019507801A (ja) | 2016-02-25 | 2019-03-22 | タクシス ファーマシューティカルズ, インコーポレイテッド | 合成プロセス及び中間体 |
ES2934785T3 (es) * | 2016-03-07 | 2023-02-27 | The Global Alliance For Tb Drug Dev Inc | Compuestos antibacterianos y usos de los mismos |
RU2629369C1 (ru) * | 2016-10-05 | 2017-08-29 | Федеральное Государственное Унитарное Предприятие "Государственный Ордена Трудового Красного Знамени Научно-Исследовательский Институт Химических Реактивов И Особо Чистых Химических Веществ" | Четвертичные аммонийные производные 2-аминотиофен-3-карбоксилатов, обладающие противотуберкулезной активностью |
CA3058183A1 (en) | 2017-03-30 | 2018-10-04 | Taxis Pharmaceuticals, Inc. | Synthetic processes and synthetic intermediates |
CN115252548A (zh) | 2017-07-14 | 2022-11-01 | 詹森药业有限公司 | 长效配制品 |
RU2661151C1 (ru) * | 2017-12-14 | 2018-07-12 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) | Селективные ингибиторы глицеральдегид-3-фосфатдегидрогеназы микобактерий |
CN113271930A (zh) | 2019-01-09 | 2021-08-17 | 詹森药业有限公司 | 治疗非结核分枝杆菌疾病的组合 |
WO2022008645A1 (en) | 2020-07-09 | 2022-01-13 | Janssen Pharmaceutica Nv | Long-acting formulations |
CA3182425A1 (en) | 2020-07-09 | 2022-01-13 | Rene Holm | Long-acting formulations |
KR20230107275A (ko) | 2020-11-12 | 2023-07-14 | 얀센 파마슈티카 엔.브이. | 비결핵성 마이코박테리아 질환의 치료에서 베다퀼린, 에탐부톨 및 마크롤라이드의 조합물 |
WO2023232838A1 (en) | 2022-05-31 | 2023-12-07 | Janssen Pharmaceutica Nv | Bedaquiline for use in the treatment of leprosy |
WO2024068693A1 (en) | 2022-09-28 | 2024-04-04 | Janssen Pharmaceutica Nv | Long-acting formulations |
WO2024068699A1 (en) | 2022-09-28 | 2024-04-04 | Janssen Pharmaceutica Nv | Long-acting formulations |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR038536A1 (es) * | 2002-02-25 | 2005-01-19 | Upjohn Co | N-aril-2-oxazolidinona-5- carboxamidas y sus derivados |
MXPA05001052A (es) * | 2002-07-25 | 2005-04-08 | Janssen Pharmaceutica Nv | Derivados de quinolina y su uso como inhibidores micobacterianos. |
-
2005
- 2005-12-05 EE EEP200500033A patent/EE05394B1/xx unknown
- 2005-12-06 CA CA2529265A patent/CA2529265C/en active Active
- 2005-12-07 AU AU2005242138A patent/AU2005242138B2/en active Active
- 2005-12-07 PA PA20058654801A patent/PA8654801A1/es unknown
- 2005-12-07 MY MYPI20055732A patent/MY145845A/en unknown
- 2005-12-08 EP EP05815816A patent/EP1830850B1/en active Active
- 2005-12-08 DE DE602005026984T patent/DE602005026984D1/de active Active
- 2005-12-08 ME MEP-2011-92A patent/ME01207B/me unknown
- 2005-12-08 BR BRPI0506400A patent/BRPI0506400B8/pt active IP Right Grant
- 2005-12-08 SI SI200531294T patent/SI1830850T1/sl unknown
- 2005-12-08 US US11/296,992 patent/US20060142279A1/en not_active Abandoned
- 2005-12-08 AT AT05815816T patent/ATE501721T1/de active
- 2005-12-08 CN CN201210507318.XA patent/CN103142595B/zh active Active
- 2005-12-08 NZ NZ555460A patent/NZ555460A/en unknown
- 2005-12-08 TW TW094143290A patent/TWI404535B/zh active
- 2005-12-08 WO PCT/EP2005/056594 patent/WO2006067048A1/en active Application Filing
- 2005-12-08 DK DK05815816.3T patent/DK1830850T3/da active
- 2005-12-08 RS RS20110221A patent/RS51730B/en unknown
- 2005-12-08 PT PT05815816T patent/PT1830850E/pt unknown
- 2005-12-08 PL PL05815816T patent/PL1830850T3/pl unknown
- 2005-12-08 TR TR2005/04892A patent/TR200504892A1/xx unknown
- 2005-12-08 AP AP2007004054A patent/AP2327A/xx active
- 2005-12-09 AR ARP050105140A patent/AR051790A1/es unknown
- 2005-12-09 LV LVP-05-161A patent/LV13469B/lv unknown
-
2007
- 2007-06-05 NI NI200700146A patent/NI200700146A/es unknown
- 2007-06-21 IL IL184123A patent/IL184123A/en active IP Right Grant
- 2007-07-20 CR CR9267A patent/CR9267A/es not_active Application Discontinuation
- 2007-07-23 NO NO20073823A patent/NO340376B1/no unknown
-
2011
- 2011-05-24 HR HR20110392T patent/HRP20110392T1/hr unknown
- 2011-06-15 CY CY20111100563T patent/CY1112247T1/el unknown
-
2013
- 2013-12-09 HK HK13113666.1A patent/HK1186125A1/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0506400A8 (pt) | Uso de um composto para a fabricação de um medicamento para o tratamento de tuberculose latente | |
BRPI0614524B8 (pt) | uso de um composto derivado de quinolina, sua combinação, composição farmacêutica, uso da referida combinação, produto, e o referido composto | |
BRPI0614493B8 (pt) | uso de um composto derivado de quinolina, sua combinação, composição farmacêutica, uso da referida combinação, produto, processo para a preparação de um composto e o referido composto | |
BRPI0614099B8 (pt) | uso de um composto derivado de quinolina, sua combinação, composição farmacêutica, uso da referida combinação, produto e o referido composto | |
JO3322B1 (ar) | مشتقات كوينولين بصفة عوامل مضادة للبكتيريا | |
MY153291A (en) | Quinoline derivatives as antibacterial agents | |
JO2695B1 (en) | Treatment of latent TB | |
TW200738237A (en) | Quinoline derivatives as antibacterial agents | |
TH80291B (th) | การรักษาวัณโรคแฝง | |
TH80291A (th) | การรักษาวัณโรคแฝง |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B15K | Others concerning applications: alteration of classification |
Ipc: C07D 215/22 (2006.01), A61P 31/06 (2006.01), C07D |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 06/04/2021, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 08/12/2005 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |